Announcements Trials
Browse Landscape

Status

Completed 3Terminated 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 25Observational 4

Sponsor

Cancer Type

Dermatologic 4

Conditions

Keratosis, Actinic 4Carcinoma, Basal Cell 2Uterine Cervical Dysplasia 1Keratosis 1

Interventions

3-ingenyl angelate 5Imiquimod 4methyl 5-aminolevulinate 2Tomography, Optical Coherence 2tirbanibulin 1Surveys and Questionnaires 1Solutions 1Microarray Analysis 1Fluorouracil 1Diclofenac 1Biopsy 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Keratosis, Actinic × Imiquimod × Clear all
NCT04809662 2024-11-07

Comparing Immune Responses to Topical Imiquimod

University of California, Davis

Terminated
6 enrolled
Dermatologic

Keratosis, Actinic

NCT00189254 2022-02-07

A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ

Viatris Inc.

Completed
72 enrolled
Dermatologic

Keratosis, Actinic

NCT02362152 2019-12-13

RAPID-ACT

LEO Pharma

Completed
1,168 enrolled
Dermatologic

Keratosis, Actinic

NCT00114023 2007-02-19

1-Year Follow up to the 1473-IMIQ Study

Graceway Pharmaceuticals, LLC

Completed
84 enrolled
Dermatologic

Keratosis, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡